Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xunfei Healthcare Technology CoHKSE:02506 +1.43%6 PS Ratio is 7.18 as of Sep. 05, 2026, which is 41% below its 10-year median of 12.24. GuruFocus rates HKSE:02506 with a GF Score™ of 6/100. The stock has 3 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Xunfei Healthcare Technology Co ranks worse than 88.35% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Xunfei Healthcare Technology Co's share price is HK$71.10.
Xunfei Healthcare Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was HK$9.90. Hence, Xunfei Healthcare Technology Co's PS Ratio for today is 7.18.
The historical rank and industry rank for Xunfei Healthcare Technology Co's PS Ratio or its related term are showing as below:
HKSE:02506'
s PS Ratio Range Over the Past 10 Years
Min: 7.18 Med: 12.24 Max: 21.51
Current: 7.18
During the past 5 years, Xunfei Healthcare Technology Co's highest PS Ratio was 21.51. The lowest was 7.18. And the median was 12.24.
HKSE:02506's PS Ratio is ranked worse than 88.35% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs HKSE:02506: 7.18
During the past 5 years, Xunfei Healthcare Technology Co's highest 3-Year average Revenue per Share Growth Rate was 24.30% per year. The lowest was 22.20% per year. And the median was 23.25% per year.
Xunfei Healthcare Technology Co (HKSE:02506) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Xunfei Healthcare Technology Co PS Ratio Related Terms
Xunfei Healthcare Technology Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02506 vs VEEV, BTSG, TEM: PS Ratio Comparison
For the Health Information Services subindustry, Xunfei Healthcare Technology Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xunfei Healthcare Technology Co PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Xunfei Healthcare Technology Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Xunfei Healthcare Technology Co's PS Ratio falls into.
Xunfei Healthcare Technology Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Xunfei Healthcare Technology Co's Share Price of today is HK$71.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xunfei Healthcare Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was HK$9.90.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Xunfei Healthcare Technology Co (HKSE:02506) has a PS Ratio of 7.18 as of Sep. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Xunfei Healthcare Technology Co and its competitors. This is 41% below median its historical median of 12.24. Over the past decade, Xunfei Healthcare Technology Co's PS Ratio has ranged from 7.18 to 21.51. According to the industry distribution chart, Xunfei Healthcare Technology Co ranks #584 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 88.4%.
Is Xunfei Healthcare Technology Co's PS Ratio too high?
Xunfei Healthcare Technology Co's current PS Ratio of 7.18 is 41% below median its 10-year median of 12.24. Over the past 10 years, this metric has ranged from a low of 7.18 to a high of 21.51. The Healthcare Providers & Services industry median PS Ratio is 1.52. Xunfei Healthcare Technology Co's value of 7.18 is 372.4% above this industry median. Based on the distribution chart, Xunfei Healthcare Technology Co ranks #584 out of 661 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Xunfei Healthcare Technology Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Xunfei Healthcare Technology Co's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Xunfei Healthcare Technology Co ranks #584 out of 661 companies for PS Ratio. This places Xunfei Healthcare Technology Co in the lower half of its industry. The industry median PS Ratio is 1.52. Xunfei Healthcare Technology Co's value of 7.18 is 372.4% above this benchmark. Historically, Xunfei Healthcare Technology Co's own PS Ratio has ranged from 7.18 to 21.51 over the past decade. While the company's 10-year median is 12.24 vs. the industry median of 1.52, Xunfei Healthcare Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xunfei Healthcare Technology Co's current PS Ratio of 7.18 is 372.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Xunfei Healthcare Technology Co and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xunfei Healthcare Technology Co's current PS Ratio is 7.18, which is 41% below median its own 10-year median of 12.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xunfei Healthcare Technology Co stock overvalued right now?
Xunfei Healthcare Technology Co (HKSE:02506) has a current PS Ratio of 7.18. The current PS Ratio is 7.18, which is 41% below median its 10-year median of 12.24 and 372.4% above the Healthcare Providers & Services industry median of 1.52. Xunfei Healthcare Technology Co's overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Xunfei Healthcare Technology Co (HKSE:02506), the current PS Ratio is 7.18 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressNo. 666 Science and Innovation Road, High-tech Zone, 4 to 5/F (North Area), No.1 Building, Anhui Province, iFLYTEK AI Research and Development Production Bas, Chengxiqiao Community Services Center, Hefei, CHN
Xunfei Healthcare Technology Co Ltd is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment, and treatment effect evaluation, to post-discharge management and chronic disease management. The company has independently developed AI technologies that underpin its products and solutions including Smart Healthcare, Smart Hospital, Smart Hardware, Smart Medical Insurance, and Smart Film Union.
6GF Score
Get the complete analysis for HKSE:02506
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02506 has been successfully added to your 
